Utilize este identificador para citar ou criar um link para este item:
http://acervodigital.unesp.br/handle/11449/7800
Registro de metadados completo
Campo DC | Valor | Idioma |
---|---|---|
dc.contributor.author | dos Santos, Jean Leandro | - |
dc.contributor.author | Lanaro, Carolina | - |
dc.contributor.author | Lima, Lidia Moreira | - |
dc.contributor.author | Gambero, Sheley | - |
dc.contributor.author | Franco-Penteado, Carla Fernanda | - |
dc.contributor.author | Aexandre-Moreira, Magna Suzana | - |
dc.contributor.author | Wade, Marlene | - |
dc.contributor.author | Yerigenahally, Shobha | - |
dc.contributor.author | Kutlar, Abdullah | - |
dc.contributor.author | Meiler, Steffen E. | - |
dc.contributor.author | Costa, Fernando Ferreira | - |
dc.contributor.author | Chung, ManChin | - |
dc.date.accessioned | 2014-05-20T13:24:49Z | - |
dc.date.accessioned | 2016-10-25T16:45:28Z | - |
dc.date.available | 2014-05-20T13:24:49Z | - |
dc.date.available | 2016-10-25T16:45:28Z | - |
dc.date.issued | 2011-08-25 | - |
dc.identifier | http://dx.doi.org/10.1021/jm200531f | - |
dc.identifier.citation | Journal of Medicinal Chemistry. Washington: Amer Chemical Soc, v. 54, n. 16, p. 5811-5819, 2011. | - |
dc.identifier.issn | 0022-2623 | - |
dc.identifier.uri | http://hdl.handle.net/11449/7800 | - |
dc.identifier.uri | http://acervodigital.unesp.br/handle/11449/7800 | - |
dc.description.abstract | A novel series of thalidomide derivatives (4a-f) designed by molecular hybridization were synthesized and evaluated in vitro and in vivo for their potential use in the oral treatment of sickle cell disease symptoms. Compounds 4a-f demonstrated analgesic, anti-inflammatory, and NO-donor properties. Compounds 4c and 4d were considered promising candidate drugs and were further evaluated in transgenic sickle cell mice to determine their capacity to reduce the levels of the proinflammatory cytokine tumor necrosis factor alpha (TNF alpha). Unlike hydroxyurea, the compounds reduced the concentrations of TNF alpha to levels similar to those induced with the control dexamethasone (300 mu mol/kg). These compounds are novel lead drug candidates with multiple beneficial actions in the treatment of sickle cell disease symptoms and offer an alternative to hydroxyurea treatment. | en |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | - |
dc.format.extent | 5811-5819 | - |
dc.language.iso | eng | - |
dc.publisher | Amer Chemical Soc | - |
dc.source | Web of Science | - |
dc.title | Design, Synthesis, and Pharmacological Evaluation of Novel Hybrid Compounds To Treat Sickle Cell Disease Symptoms | en |
dc.type | outro | - |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | - |
dc.contributor.institution | Universidade Estadual de Campinas (UNICAMP) | - |
dc.contributor.institution | Universidade Federal do Rio de Janeiro (UFRJ) | - |
dc.contributor.institution | Universidade Federal de Alagoas (UFAL) | - |
dc.contributor.institution | Med Coll Georgia | - |
dc.description.affiliation | Univ Estadual Paulista UNESP, Fac Ciencias Farmaceut, Dept Farmacos & Med, Lab Pesquisa & Desenvolvimento Farmacos Lapdesf, BR-14801902 Araraquara, SP, Brazil | - |
dc.description.affiliation | Univ Campinas UNICAMP, Haematol & Haemotherapy Ctr, Hemoctr, BR-13083970 Campinas, SP, Brazil | - |
dc.description.affiliation | Univ Fed Rio de Janeiro, Fac Farm, Lab Avaliacao & Sintese Subst Bioat, BR-21944971 Rio de Janeiro, Brazil | - |
dc.description.affiliation | Universidade Federal de Alagoas (UFAL), Inst Ciencias Biol & Saude, Lab Farmacol & Imunidale LaFI, Maceio, AL, Brazil | - |
dc.description.affiliation | Med Coll Georgia, Dept Anesthesiol & Perioperat Med, Augusta, GA 30912 USA | - |
dc.description.affiliation | Med Coll Georgia, Sickle Cell Ctr, Augusta, GA 30912 USA | - |
dc.description.affiliationUnesp | Univ Estadual Paulista UNESP, Fac Ciencias Farmaceut, Dept Farmacos & Med, Lab Pesquisa & Desenvolvimento Farmacos Lapdesf, BR-14801902 Araraquara, SP, Brazil | - |
dc.description.sponsorshipId | FAPESP: 10/12495-6 | - |
dc.description.sponsorshipId | FAPESP: 07/56115-0 | - |
dc.identifier.doi | 10.1021/jm200531f | - |
dc.identifier.wos | WOS:000294077300014 | - |
dc.rights.accessRights | Acesso restrito | - |
dc.relation.ispartof | Journal of Medicinal Chemistry | - |
Aparece nas coleções: | Artigos, TCCs, Teses e Dissertações da Unesp |
Não há nenhum arquivo associado com este item.
Itens do Acervo digital da UNESP são protegidos por direitos autorais reservados a menos que seja expresso o contrário.